Govt May Get Oxford Shots In Jan-Feb, At 50% Of MRP
New Delhi : India is likely to get the first lot of anti-Covid shots in late January-early February which will allow some frontline workers like doctors, nurses and municipal staff to…
Covid will soon be past episode of 21st century: Harsh Vardhan
NEW DELHI: The rapidness at which coronavirus vaccines are being developed will have a significant effect on new technologies that will help in faster drug discoveries, lowering the cost and making it…
WHO Removes Remdesivir From List of COVID-19 Medicines
New Delhi: The World Health Organisation (WHO) has stated that it has suspended Gilead Sciences’ antiviral drug remdesivir, which was touted as COVID-19 treatment, from its prequalification list—- an official list…
Medical Devices: Atmanirbhar Versus Burden of Whopping Import Bill on India
New Delhi: PM Narendra Modi’s invocation of Atmanirbhar Bharat (self reliant India) after depletion of Indian economy due to COVID catastrophe has led to great churning in country’s every domain.…
Atmanirbhar India in Accurate & Speedy COVID-19 Testing from December
New Delhi: Apollo hospitals group has introduced first of its kind indigenously developed and AI powered COVID 19 testing method which epitomises speed and accuracy, attributes lacking so far in…
Govt Job for Pharmacist under ECHS
The ECHS Central Organisation is located at Delhi and functions under the Chief of Staff Committee (COSC) through AG and DGDC&W in Army HQ. The Central organisation is headed by…
Everybody Can’t Be Allowed To Prescribe Medicines For Treatment, Says SC
New Delhi : Everybody cannot be allowed to prescribe medicines, observed the Supreme Court on Thursday while hearing an appeal against the Kerala High Court order which had said that AYUSH…
US FDA Approves First At-Home Coronavirus Test
Emeryville : The first COVID-19 diagnostic at-home self-test that provides rapid results has been approved by the U.S. Food and Drug Administration, the agency announced Tuesday. The Lucira COVID-19 All-In-One…
Delhi High Court Rejects AstraZeneca’s Plea On Dapagliflozin Drug Patent
Mumbai : The Delhi high court has rejected global pharma major AstraZeneca’s application seeking a restraining order against marketing of a blockbuster anti-diabetes drug Dapagliflozin by domestic companies, including Torrent, USV,…
As Women rise, Lung Cancer in them have risen too
New Delhi: For the past few years winters in the North of India have been particularly tough as majority of the cities get engulfed in a thick blanket of smog…
